Inhalant dependence with inhalant-induced psychotic disorder
ICD-10 F18.25 is a billable code used to indicate a diagnosis of inhalant dependence with inhalant-induced psychotic disorder.
Inhalant dependence with inhalant-induced psychotic disorder is characterized by a compulsive pattern of inhalant use leading to significant impairment or distress. Inhalants, which include a variety of substances such as solvents, aerosols, and gases, can induce a state of intoxication that may result in psychotic symptoms such as hallucinations, delusions, and disorganized thinking. The diagnosis requires evidence of inhalant dependence, which is marked by tolerance, withdrawal symptoms, and a persistent desire to use inhalants despite negative consequences. The inhalant-induced psychotic disorder must be distinguished from primary psychotic disorders, as the symptoms are directly attributable to the use of inhalants. Treatment typically involves a combination of behavioral therapies, counseling, and support groups, focusing on cessation of inhalant use and management of psychotic symptoms. Long-term recovery may require ongoing support and monitoring to prevent relapse.
Comprehensive mental health evaluation, including history of substance use and current mental status.
Patients presenting with acute psychosis following inhalant use, or chronic users with deteriorating mental health.
Ensure clear documentation of the timeline of inhalant use and onset of psychotic symptoms.
Detailed substance use history, including frequency, quantity, and types of inhalants used.
Patients in withdrawal from inhalants or those seeking treatment for inhalant dependence.
Document any co-occurring disorders and the treatment plan for both inhalant dependence and mental health issues.
Used for initial evaluation of patients with inhalant dependence.
Comprehensive assessment including substance use history and mental health evaluation.
Psychiatry and addiction medicine should ensure thorough documentation of inhalant use.
Inhalant dependence refers to the compulsive use of inhalants leading to significant impairment, while inhalant-induced psychotic disorder specifically involves the presence of psychotic symptoms directly related to inhalant use.
